10 mg · 20 mg · 30 mg · 50 mg
Retatrutide
Investigational peptide targeting GIP, GLP-1 and glucagon receptors. Studied in clinical trials on body weight and glycemic control.
For research use only
MOTS-C
Mitochondrial-derived peptide studied in preclinical models of insulin sensitivity, metabolic adaptation and physical capacity.
- Pay by card (Stripe) or Zelle
- Ships within the U.S. with tracking
- Questions? Call or email us
Benefits under study
Preclinical research in mice.
- Insulin sensitivity
- Metabolic adaptation
- Physical capacity
Research overview
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, part of a small group of mitochondrial-derived peptides studied in cellular energy regulation, glucose metabolism, insulin sensitivity, mitochondrial signaling and exercise-related adaptation.
Studies in mice have examined its role in insulin sensitivity and metabolic homeostasis (Cell Metabolism, 2015) and in physical capacity and muscle homeostasis with age (Nature Communications, 2021).
Supplied as a 40 mg vial for laboratory research.
Scientific references
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Cell Metab, 2015 · PMID 25738459
View on PubMedMOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Nat Commun, 2021 · PMID 33473109
View on PubMed
You may also need
10 mg · 20 mg
Tesamorelin
GHRH analog studied in GH/IGF-1 signaling and visceral fat, including trials in people with HIV and altered fat distribution.
100 mg
KLOW
Blend of GHK-Cu, BPC-157, TB-500 and KPV. Studies on the individual components do not evaluate the blend.